Morepen Laboratories surged 8.90% to Rs 46.61 after the company launched Empamore, an affordable treatment for type 2 diabetes, heart failure, and chronic kidney disease in India.

Loratadine's Heir Apparent Available for Allergy Season Drugs Similar, But Not the Same Agent Performed Well in Trials Agent May Prove as Profitable as Loratadine Sidebar: At a Glance ...